ArticleScientific reports2017

Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells.

Eva Serrano-Candelas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.